ID: ALA3888851
Type: Binding
Description: Radioligand Binding (mouse TAAR1): HEK-293 cells stably expressing mouse TAAR1 were maintained at 37° C. and 5% CO2 in DMEM high glucose medium, containing fetal calf serum (10%, heat inactivated for 30 min at 56° C.), penicillin/streptomycin (1%), and 375 μg/ml geneticin (Gibco). Cells were released from culture flasks using trypsin/EDTA, harvested, washed twice with ice-cold PBS (without Ca2+ and Mg2+), pelleted at 1'000 rpm for 5 min at 4μ C., frozen and stored at −80° C. Frozen pellets were suspended in 20 ml HEPES-NaOH (20 mM, pH 7.4) containing 10 mM EDTA and homogenized with a Polytron (PT 6000, Kinematica) at 14'000 rpm for 20 s. The homogenate was centrifuged at 48'000×g for 30 min at 4° C. Subsequently, the supernatant was removed and discarded, and the pellet resuspended in 20 ml HEPES-NaOH (20 mM, pH 7.4) containing 0.1 mM EDTA using the Polytron (20 s at 14'000 rpm). This procedure was repeated and the final pellet resuspended in HEPES-NaOH containing 0.1 mM EDTA and homogenized using the Polytron. Typically, aliquots of 2 ml membrane portions were stored at −80° C. With each new membrane batch the dissociation constant (Kd) was determined via a saturation curve. The TAAR1 radioligand 3[H]−(S)-4-[(ethyl-phenyl-amino)-methyl]-4,5-dihydro-oxazol-2-ylamine (described in WO 2008/098857) was used at a concentration equal to the calculated Kd value, that was usually around 0.7 nM, resulting in the binding of approximately 0.5% of the radioligand and a specific binding representing approximately 70% of the total binding. Nonspecific binding was defined as the amount of 3[H]−(S)-4-[(ethyl-phenyl-amino)-methyl]-4,5-dihydro-oxazol-2-ylamine bound in the presence of 10 μM unlabeled ligand. All compounds were tested at a broad range of concentrations (10 pM to 10 μM) in duplicates. The test compounds (20 μl/well) were transferred into a 96 deep well plate (TreffLab), and 180 μl of HEPES-NaOH (20 mM, pH 7.4) containing MgCl2 (10 mM) and CaCl2 (2 mM) (binding buffer), 300 μl of the radioligand 3[H]−(S)-4-[(ethyl-phenyl-amino)-methyl]-4,5-dihydro-oxazol-2-ylamine at a concentration of 3.3×Kd in nM and 500 μl of the membranes (resuspended at 60 μg protein per ml) added. The 96 deep well plates were incubated for 1 hr at 4° C. Incubations were terminated by rapid filtration through Unifilter-96 plates (Packard Instrument Company) and glass filters GF/C (Perkin Elmer) presoaked for 1 hr in polyethylenimine (0.3%) and washed 3 times with 1 ml of cold binding buffer. After addition of 45 μl of Microscint 40 (PerkinElmer) the Unifilter-96 plate was sealed and after 1 hr the ratioactivity counted using a TopCount Microplate Scintillation Counter (Packard Instrument Company).
Organism: Mus musculus
Cell type: HEK293
Bioactivity
Activity Types for Assay ALA3888851
Ki
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
349.39 | 2.18 | 2.18 |
363.42 | 2.49 | 2.49 |
399.40 | 3.20 | 3.20 |
347.42 | 2.99 | 2.99 |
333.39 | 2.60 | 2.60 |
415.40 | 2.78 | 2.78 |
433.39 | 3.08 | 3.08 |
383.84 | 2.83 | 2.83 |
367.38 | 2.32 | 2.32 |
383.84 | 2.83 | 2.83 |
393.45 | 2.58 | 2.58 |
393.45 | 2.58 | 2.58 |
433.39 | 3.08 | 3.08 |
415.40 | 2.78 | 2.78 |
415.40 | 2.78 | 2.78 |
417.39 | 3.20 | 3.20 |
379.42 | 2.19 | 2.19 |
393.45 | 2.58 | 2.58 |
363.42 | 2.49 | 2.49 |
349.39 | 2.18 | 2.18 |
379.42 | 2.19 | 2.19 |
367.38 | 2.32 | 2.32 |
429.28 | 2.34 | 2.34 |
433.39 | 3.08 | 3.08 |
393.45 | 2.58 | 2.58 |
379.42 | 2.19 | 2.19 |
363.42 | 2.49 | 2.49 |
417.39 | 3.20 | 3.20 |
379.42 | 2.19 | 2.19 |
363.42 | 2.49 | 2.49 |
363.42 | 2.49 | 2.49 |
363.42 | 2.49 | 2.49 |